iCardiac Overview
- Founded
- 2006

- Status
- Acquired/Merged
- Employees
- 200

- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 7
- Investments
- 1
iCardiac General Information
Description
Provider of cardiac safety and respiratory services intended to help drug development program run more efficiently. The company's on-demand expertise for cardiac safety and respiratory services include High Precision QT and Early Precision QT methodologies that sets a new standard for precision and accuracy in all phases of human drug trials, to ensure that subjects are not inappropriately included or excluded from studies, enabling small and mid-sized pharma and biotech companies to advance in the field of cardiac safety.
Contact Information
- 150 Allens Creek
- Rochester, NY 14618
- United States
iCardiac Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore iCardiac‘s full profile, request access.
Request a free trialiCardiac Comparisons
Industry
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialiCardiac Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
0000000 | Formerly PE-Backed | Bethesda, MD | 000 | 000000000000 |
iCardiac Patents
iCardiac Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130096447-A1 | System and methods for serial analysis of electrocardiograms | Abandoned | 27-Sep-2011 | 000000000 | 00 |
US-20110184296-A1 | Method and system for quantitative assessment of cardiac electrical events | Abandoned | 27-Jan-2010 | 000000000 | 0 |
US-20110112414-A1 | System for automated ekg analysis | Abandoned | 06-Nov-2009 | 000000000 | 0 |
US-20110105928-A1 | Ecg reconstruction for atrial activity monitoring and detection | Abandoned | 05-Nov-2009 | 0000000000 | 00 |
US-20100317985-A1 | System for quantitative assessment of cardiac electrical events | Abandoned | 12-Jun-2009 | A61B5/316 | 0 |
iCardiac Executive Team (16)
iCardiac Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
0. 000000 000000000 | Self | Co-Founder, Chief Innovation Officer and Board Member | 000 0000 |
iCardiac Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialiCardiac Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore iCardiac‘s full profile, request access.
Request a free trialiCardiac Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 | 06-Aug-2015 | 0000000000 | Other Healthcare Services | 000000000 |